Table 4 |
||||
|
Estimation of tumor cell sub-clone content by segmentation for hemizygous loss in CLL samples |
||||
|
Sample* |
CLL cells (%)† |
Genomic region |
Hemizygous loss by FISH (%) |
Hemizygous loss by segmentation (%)‡ |
|
|
||||
|
8 |
87 |
17p13.3-p11.1 |
73 |
77 |
|
9 |
90 |
11q22.1-q23.3 |
56 |
58 |
|
10 |
86 |
17p13.3-p11.2 |
90 |
94 |
|
|
||||
|
*Data set 4. mBAF cut-off for each sample based on the maximum theoretical value for copy neutral LOH for the respective tumor content. †Percent CLL cells (CD5+/CD23+) were estimated by flow cytometry. ‡The average segmented value for the region was used. |
||||
|
Staaf et al. Genome Biology 2008 9:R136 doi:10.1186/gb-2008-9-9-r136 |
||||